Behavioral and Neurophysiological Effects of Transdermal Rotigotine in Atypical Parkinsonism

Effective therapies for the so-called atypical parkinsonian syndrome (APS) such as multiple system atrophy (MSA), progressive supranuclear palsy (PSP), or corticobasal syndrome (CBS) are not available. Dopamine agonists (DA) are not often used in APS because of inefficacy and in a minority of case,...

Descripción completa

Detalles Bibliográficos
Autores principales: Moretti, Davide Vito, Binetti, Giuliano, Zanetti, Orazio, Frisoni, Giovanni Battista
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046164/
https://www.ncbi.nlm.nih.gov/pubmed/24926284
http://dx.doi.org/10.3389/fneur.2014.00085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046164/
https://www.ncbi.nlm.nih.gov/pubmed/24926284
http://dx.doi.org/10.3389/fneur.2014.00085

Ejemplares similares